Bipartisan Bill Proposed: What is Predicted of the Stock Market?

Politicians seem to have some of the best performing investment portfolios which is why the BiPartisan Restoring Faith in Government Act was introduced to prohibit congress member stock market trading. The bipartisan bill is sponsored by GOP Reps Matt Gaetz and Brian Fitzpatrick alongside Alexandria Ocasio-Cortez, amongst others.

On this episode of Untamed Ethos, host Dr. Joshua Wilson, who recently successfully defended his PhD dissertation, chats with guest Dr. Russell Rhoads, a Clinical Associate Professor at the Indiana University Kelley School of Business. The two discuss a new bipartisan bill that has been proposed that would prohibit stock trading in Congress.

Wilson was quick to propose that this marked a great opportunity for investment advisors to speak out in favor of the retail client. But in a capitalist society, should congress members be banned from being allowed to own stock and trade?

Rhoads noted, “If you go into Congress, you probably should, there should be some sort of mechanism in there where you get a money manager that, you know, uses one of those CFA, cookie-cutter solutions…and here’s how we’re going to allocate for you.”

Dr. Rhoads and Dr. Wilson also discuss…

● How current events affect market volatility

● Where the state of the stock market lies

● Rhoads’ prediction on the outlook of the stocks in the coming years

“The most favored number is a 25-basis point cut in September, and I just don’t see that happening and I gotta figure out how to go about trading this because the only way you can really make money trading fixed income is if you have a different opinion than the rest of the market,” said Rhoads.

Russell Rhoads, PhD, was previously head of research at EQDerivatives. He is now an Associate Clinical Professor at the Kelley School of Business at Indiana University. He has over three decades of experience in the trading and financial market industries. Rhoads is also a published author, including Candlestick Charting for Dummies, and The VIX Trader’s Handbook, amongst others.

Follow us on social media for the latest updates in B2B!

Image

Latest

whole health index
Whole Health Index
May 22, 2025

Dr. Sam Ambewadikar returns to break down Anthem’s Whole Health Index (WHI)—a powerful tool that distills medical, social, environmental, and behavioral data into a single score (0–100) to identify members most at risk. By surfacing factors like transportation deserts, housing instability, or food insecurity, WHI enables Anthem care managers and advocates to proactively match members…

Read More
pcp
PCP Attribution Analysis
May 22, 2025

Dr. Sam Ambewadikar, RVP and Medical Director at Anthem National Accounts, joins Brent to unpack the power of primary care attribution analysis—a tool he helped pioneer to spotlight the clinical and financial impact of members not having an established PCP. Drawing from his background as a practicing pediatrician and claims analytics leader, Dr. Sam shares…

Read More
sydney health
Sydney Health Demo
May 22, 2025

In this episode, Christina Firouztash, Executive Advisor of Digital Solutions at Anthem, gives a dynamic walkthrough of the Sydney Health app—Anthem’s flagship digital member experience. Christina showcases how Sydney delivers personalized, simple, and equitable navigation across benefits, including virtual care, pharmacy, financial transparency, and social services access. From contextual chatbots and ID card access to…

Read More
pharmacy
Pharmacy Part 1
May 22, 2025

In this episode, Brent chats with Katie Brennan, National Sales Director at CarelonRx, about making pharmacy benefits more accessible, consistent, and member-friendly. Katie spotlights Carelon new advanced home delivery model, which brings the pharmacy counter—and the pharmacist—into the member’s home. With fewer retail pharmacies offering extended hours and many patients lacking reliable transportation, CarelonRx is…

Read More